The independent source for health policy research, polling, and news.
36,501 - 36,520 of 112,633 Results
In other pharmaceutical and marketplace news, the Food and Drug Administration rejects Amgen's petition for a new application for its hormonal imbalance therapy drug. And KQED reports on Silicon Valley's new focus on nootropics.
Meanwhile, a study finds that paid sick leave reduces cases of the flu because workers are more inclined to stay home when sick. And homeless advocates and public health officials are at odds over the Obama administration's plan for a smoking ban in public housing.
An earlier review by the International Agency for Research on Cancer linked excess body fat to five types of cancer, while its latest study adds eight more to that list. In other news on the disease, media outlets report on a gene test that may help predict when a woman with breast cancer can skip chemotherapy.
NBC News reports that the state is using a chemical that has been banned in Europe, and The New York Times reports on how some people are growing uneasy about the roles of science and government. Meanwhile, attention is now focusing on the need for more information related to the first non-travel case of Zika identified in the Tampa area.
This information is viewed as more bad news because it suggests that the virus may continue to cause damage during this time when the brain is rapidly growing and developing.
Prescriptions drug costs, how to handle public health crises like Zika and Ebola and the candidates' health records all make headlines from the presidential campaign trail.
As lawmakers on Capitol Hill increasingly call for an investigation regarding the soaring costs of Mylan Pharmaceuticals' EpiPen, there is a twist. The company's CEO is Heather Bresch, who is the daughter of Sen. Joe Manchin, D-W.Va.
Stat reports that some legal analysts say that Mylan's provision of its emergency allergy treatment to schools at a discounted price may have been an antitrust violation. Meanwhile, senators who backed legislation encouraged schools to stock the EpiPen are now among those calling for an investigation of the product's price hike.
Under the weight of the criticism, stock prices for Mylan, the manufacturer of the Epi-Pen, fell 5.4 percent on Wednesday and 4.8 percent the day before. Meanwhile, news outlets examine the steps that led to the dramatic price increase and reaction from policy makers and even local physicians.
The drugmaker announces that it will increase the amount on a copay savings card from $100 to $300 and expand eligibility criteria for patients who can receive the drug for free.
Gov. Matt Bevin's administration submitted the waiver request to the federal Department of Health and Human Services for review and approval. The Obama administration has previously balked at similar provisions in another request that would require recipients to work or volunteer 20 hours a week.
The government analysis finds that subsidies to help pay premiums will protect people buying coverage on the health law's marketplaces even as the number of insurers offering plans decreases and insurers set steep premium increases.
The numbers for 2017 premiums for marketplace plans are slowly coming out and show a wide range of increases. Tennessee authorities approved a 62 percent increase for one of the state's biggest plans, while in Ohio the hikes start at more than 12 percent. Other insurance news from Illinois and Wisconsin.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Recent commentaries about drug-cost issues.
News outlets report on more stories related to pharmaceutical drug pricing.
Researchers examine thousands of studies to determine why prices for medications have climbed and what might be done about it.
Outlets report on health news from California, Connecticut, Wisconsin, Florida, New Hampshire, Pennsylvania, Minnesota, Missouri, Tennessee, Ohio and Maryland.
News outlets also report on parents' attitude toward the HPV vaccine, how job satisfaction impacts health later in life, the connection between online devices and sleep quality as well as the latest on two transplant procedures.
© 2026 KFF